跳至主要内容
临床试验/TCTR20181221001
TCTR20181221001招募中未知

Effect of Vitamin B12, Folate, and Entacapone in Levodopa-induced hyperhomocysteinemia

Research and Development Center, Prapokklao Hospital0 个研究点目标入组 62 人开始时间: 2018年12月21日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 90 Years(—)
性别
All

入选标准

  • The PD patients who are being treated with levodopa at least 300 mg/day for at least 1 year.

排除标准

  • 1. Patients who are being treated with entacapone
  • 2. Patients who are taking vitamin B12 or folate supplement.
  • 3. Presence of the conditions influence homocysteine level are end stage renal disease, liver cirrhosis, smoking, malignancy, dementia, diabetes mellitus, hypothyroid, take thaizide diuretic, azathioprine, phenytoin, metrotrexate

研究者

发起方
Research and Development Center, Prapokklao Hospital

相似试验